Quotes for Arcede Pharma AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Erik Magnusson (tf)
Chairperson of the Board
- Ingemar Kihlström
Board
- Åsa Kornfeld
- Johanna Asklin
- Laurent Pacheco
Arcede Pharma AB
Arcede Pharma is a pharmaceutical company. The company conducts research and development in the field of chronic obstructive pulmonary disease, also abbreviated as COPD, and severe asthma. The company's product portfolio includes medicines intended for the treatment and relief of the above ailments. The largest activity is found within the Nordic market. The company was created via a spin-off of Respiratorius in 2022 and today has its headquarters in Lund.
News
- Arcede Pharmas ansökan om avnotering godkänd av Spotlight
- Likvidator till Arcede Pharma utsedd
- Kommuniké från extra bolagsstämma i Arcede Pharma AB den 17 juli 2024
- Kallelse till extra bolagsstämma i Arcede Pharma AB
- Arcede Pharma föreslår frivillig likvidation av bolaget och avser att ansöka om avnotering av bolagets aktier
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Christer Fåhraeus | 13,66 | 13,66 | 2024-06-26 |
| Avanza Pension | 7,67 | 7,67 | 2024-06-26 |
| Ben Hayes | 4,13 | 4,13 | 2024-06-26 |
| Tord Holmberg | 3,96 | 3,96 | 2024-06-26 |
| Hans Harvig | 2,47 | 2,47 | 2024-06-26 |
| Christian Lentz | 2,15 | 2,15 | 2024-06-26 |
| Christian Müller | 1,77 | 1,77 | 2024-06-26 |
| Hans Jönsson | 1,60 | 1,60 | 2024-06-26 |
| Hans Mandahl | 1,48 | 1,48 | 2024-06-26 |
| Konsult I Beddingestrand AB | 1,25 | 1,25 | 2024-06-26 |
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream